| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |